Acorda Therapeutics Announces Data on AMPYRA(TM) (dalfampridine) Presented at ... - MarketWatch (press release)

Submitted by Google Search on


Acorda Therapeutics Announces Data on AMPYRA(TM) (dalfampridine) Presented at ...
MarketWatch (press release)
AMPYRA is a potassium channel blocker approved as a treatment to improve walking in patients with multiple sclerosis (MS). This was demonstrated by an ...
Acorda Therapeutics Announces Data on AMPYRA(TM) (dalfampridine) Presented at ...istockAnalyst.com (press release)

all 18 news articles »

Add new comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

Filtered HTML

  • Web page addresses and e-mail addresses turn into links automatically.
  • Allowed HTML tags: <a> <em> <strong> <cite> <code> <ul> <ol> <li> <dl> <dt> <dd>
  • Lines and paragraphs break automatically.